Proteomic profiling identifies haptoglobin as a potential serum biomarker for steroid-resistant nephrotic syndrome

American Journal of Nephrology

Volumn 36, Issue 2, 2012, Pages 105-113

  Wen, Qiong ^a   Huang, Lan Ting ^a   Luo, Ning ^a   Wang, Yong Tao ^a   Li, Xiao Yan ^a   Mao, Hai Ping ^a   Zhang, Li ^a   Dong, Xiu Qing ^a   Yu, Xue Qing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Biomarkers; Nephrotic syndrome; Proteomics; Steroid resistance

Indexed keywords

HAPTOGLOBIN;

ADULT; ARTICLE; BLOOD SAMPLING; CONGENITAL NEPHROTIC SYNDROME; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; ISOELECTRIC POINT; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; NEPHROTIC SYNDROME; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SENSITIVITY AND SPECIFICITY; STEROID SENSITIVE NEPHROTIC SYNDROME; TWO DIMENSIONAL ELECTROPHORESIS; URINALYSIS; WESTERN BLOTTING;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHOLESTEROL; CREATININE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HAPTOGLOBINS; HUMANS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; YOUNG ADULT;

EID: 84863109408     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000339755     Document Type: Article

References (26)

1. Tune BM, Mendoza SA: Treatment of the idiopathic nephritic syndrome: regimens and outcomes in children and adults. J Am Soc Nephrol 1997;8:824-832. (Pubitemid 27493599)
2. Ponticelli C, Passerini P, Altieri P, et al: Remissions and relapses in idiopathic membranous nephropathy. Nephrol Dial Transplant 1992;7(suppl 1):85-90. (Pubitemid 23016773)
3. Ghiggeri GM, Catarsi P, Scolari F, et al: Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study. Clin Ther 2004;26:1411-1418. (Pubitemid 39572155)
4. Meryl Waldman, R. John Crew, Anthony Valeri, et al: Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol 2007;2:445-453.
5. Mak SK, Short CD, Mallick NP: Long-term outcome of adult-onset minimal change nephropathy. Nephrol Dial Transplant 1996;11:2192-2201. (Pubitemid 26385914)
6. Korbet SM, Rydel J, Schwartz M, et al: The prognosis of focal segmental glomerular sclerosis in adults. J Am Soc Nephrol 1993;4:280.
7. Troyanov S, Wall CA, Miller JA, et al: Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J Am Soc Nephrol 2005;16:1061-1068. (Pubitemid 41710316)
8. Kimura M, Toyoda M, Kobayashi K, et al: A retrospective study on the efficacy of corticosteroidalone therapy in membranous nephropathy patients. Intern Med 2007;46:1641-1645. (Pubitemid 350111156)
9. Anderson NL, Anderson NG: The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002;1:845-867.
10. Chromy BA, Gonzales AD, Perkins J, Choi MW, et al: Proteomic analysis of human serum by two-dimensional differential gel electrophoresis after depletion of highabundant proteins. J Proteome Res 2004;3:1120-1127. (Pubitemid 40040365)
11. Moshkovskii SA, Serebryakova MV, Kuteykin-Teplyakov KB, et al: Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1. Proteomics 2005;5:3790-3797. (Pubitemid 41393309)
12. Khurana M, Traum AZ, Aivado M, et al: Urine proteomic profiling of pediatric nephrotic syndrome. Pediatr Nephrol 2006;21:1257-1265. (Pubitemid 44203451)
13. Woroniecki RP, Orlova TN, Mendelev N, et al: Urinary proteome of steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome of childhood. Am J Nephrol 2006;26:258-267. (Pubitemid 44114396)
14. Haugen TH, Hanley JM, Heath EC: Haptoglobin: a novel mode of biosynthesis of a liver secretory glycoprotein. J Biol Chem 1981;256:1055-1057. (Pubitemid 11157202)
15. Engstrom G, Stavenow L, Hedblad B, et al: Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a populationbased study. Diabetes 2003;52:42-447.
16. D'Armiento J, Dalal SS, Chada K: Tissue, temporal and inducible expression pattern of haptoglobin in mice. Gene 1997;195:19-27. (Pubitemid 27336956)
17. Cid MC, Grant DS, Hoffman GS, et al: Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 1993;91:977-985. (Pubitemid 23095272)
18. Langlois MR, Delanghe JR: Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996;42:1589-1600. (Pubitemid 26354735)
19. Tencer J, Thysell H, Westman K, Rippe B: Elevated plasma levels of acute phase proteins in mesangioproliferative glomerulonephritis, membranous nephropathy and IgA nephropathy. Scand J Urol Nephrol 1995;29:5-9.
20. Heidi Hoi-Yee Ngai, Wai-Hung Sit, Ping-Ping Jiang, et al: Markedly increased urinary preprohaptoglobin and haptoglobin in passive Heymann nephritis: a differential proteomics approach. J Proteome Res 2007;6:3313-3320. (Pubitemid 47310215)
21. Mathieson PW: Role of the podocyte in glomerular injury. Hong Kong J Nephrol 2001;3:51-55.
22. Wiggins RC: The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 2007;71:1205-1214. (Pubitemid 46884251)
23. Shalhoub RJ: Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 1974;ii:556-560.
24. Mathieson PW: Immune dysregulation in minimal change nephropathy. Nephrol Dial Transplant 2003;18(suppl 6):V126-V129.
25. Sher ER, Surs W, Kam JC, et al: Characterization of T lymphocytes and glucocorticoid receptors in steroid resistant asthma. J. Allergy Clin Immunol 1992;89:285.
26. Donald Y, Leung M, Martin RJ, Szefler SJ, et al: Dysregulation of interleukin 4, interleukin 5, and interferon γ gene expression in steroid-resistant asthma. J Exp Med 1995;181:33-40.